IFNG and congenital rubella syndrome: CRS usually occurs within the first two week of CAR-T infusion and is thought to be related to the upregulation and release of IL-1, IL-2, IL-6, interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNFα) from immune cells, especially monocytes/macrophages [31,32,33].